Project Grant HT94252310247
Award Date 9/15/23
Completion Date 9/14/26
Dollars Obligated $592K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Salt Lake City, UT 84112, USA
Similar Awards
- The Defense Health Agency awarded a Project Grant titled "PROGESTIN THERAPY FOR ENDOMETRIAL CANCER" to the University of Utah in the amount of $470,919.00 under the Military Medical Research and Development program (CFDA 12.420). The grant, with a period of performance from August 1, 2023 to July 31, 2027, will fund research to investigate medical solutions for the battlefield, with a focus on transforming healthcare for Service Members and the American public through innovative and...
- This Project Grant award of $1,539,469.00 from the Defense Health Agency was provided to the University of Utah under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "Molecular Crosstalk Between Estrogens and Progestogens in Endometrial Cancer." The award will fund this biomedical research project from September 1, 2023 to August 31, 2026. The University of Utah has an extensive track record of collaborating with government agencies on...
- The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,260,839 Project Grant to the University of Colorado-Denver. The grant, titled "Targeting EHMT1/2 to Overcome Therapy-Resistant Ovarian Cancer," will fund advanced biomedical research aimed at developing novel diagnostic tools and therapeutic interventions for ovarian cancer. The research project, spanning from May 2025 to April 2029, will investigate the role of the...
- The Defense Health Agency has awarded a $968,400 Project Grant to Mayo Clinic to develop a personalized approach to treating drug-resistant ovarian cancer. The grant, which began on June 1, 2024, and will run through May 31, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research to improve the health and care of military service members, veterans, and their families. Through this award, Mayo Clinic will leverage its...
- This federal Project Grant award, valued at $538,998.00 and provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), aims to enhance the antitumor myeloid immune response for the treatment of adrenocortical carcinoma. The award was made to the University of Utah's Office of Sponsored Projects Division, a major recipient of federal funding that conducts cutting-edge biomedical research. The funding will support a research project focused...
- The Defense Health Agency awarded Rutgers, The State University of New Jersey a $942,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support targeted chemotherapeutic and immunotherapeutic research for drug-resistant ovarian cancer. The three-year award beginning April 1, 2023 will fund Rutgers Biomedical and Health Sciences' investigation into medical solutions for this treatment-resistant form of ovarian cancer through innovative research...
- The University of Colorado was awarded a $577,680.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research to target EHMT1/2 to overcome therapy-resistant ovarian cancer. The project aims to transform healthcare for military service members, veterans, and the broader public by developing novel diagnostic tools, therapeutic interventions, and clinical practice guidelines to address critical health...
- The Defense Health Agency awarded a $1,555,000 project grant to the University of Wisconsin System for the "Population Modeling to Optimize Equitable Ovarian Cancer Outcomes" research program under the Military Medical Research and Development (CFDA 12.420) federal grant program. The project, running from April 2025 to April 2029, will focus on advanced biomedical research to transform healthcare for military service members, veterans, and the public by developing novel diagnostic...
- The University of Utah has been awarded a $1,232,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETING IRON-SULFUR CLUSTER ASSEMBLY A NOVEL VULNERABILITY IN KIDNEY CANCER," will fund research focused on developing new treatment approaches for kidney cancer. The award period runs from July 1, 2024, through June 30, 2028. This federal grant program supports a range of biomedical...
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $467,742 Project Grant to the Regents of the University of Michigan to optimize a risk stratification model for ovarian cancer. The award will support research activities from September 1, 2024 through August 31, 2026. The University of Michigan, a top public research institution, has extensive experience conducting federal research and development projects for agencies such as the...